CBFP
BSX icon

Cedar Brook Financial Partners’s Boston Scientific BSX Stock Holding History

Cedar Brook Financial Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,522
Closed -$204K – 254
2019
Q4 		$204K Buy
+4,522
New +$189K 0.09% 275
2019
Q3 		– Sell
-4,910
Closed -$211K – 305
2019
Q2 		$211K Buy
+4,910
New +$189K 0.1% 274

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Cedar Brook Financial Partners's BSX Position: Q1 2020 in Review

Cedar Brook Financial Partners sold out of Boston Scientific (BSX) in Q1 2020, closing a stake of 4,522 shares — an estimated $204K sold.

Cedar Brook Financial Partners first reported a position in BSX in Q2 2019 and held it in 2 quarters. The position peaked at $211K in Q2 2019. 800 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

  • Cedar Brook Financial Partners reported no remaining Boston Scientific position as of Q1 2020 after selling out during the quarter.
  • Cedar Brook Financial Partners sold 4,522 Boston Scientific shares in Q1 2020, an estimated $204K.
  • Cedar Brook Financial Partners first reported a position in Boston Scientific in Q2 2019 and held it in 2 quarters.
  • Cedar Brook Financial Partners's Boston Scientific position peaked at $211K in Q2 2019.
  • 800 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on Cedar Brook Financial Partners's 13F filing for Q1 2020, filed 7 May 2020.